Overall, meta-analysis of these studies using 29 experimental and 27 control animals suggested that IL-17 inhibition led to a significantly smaller AAA diameter in experimental animals compared to controls, with a large effect size and low heterogeneity (Figure 1E). The gene discussed is IL17A; the disease is triple-A syndrome.